SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-011212
Filing Date
2024-04-05
Accepted
2024-04-05 16:06:59
Documents
16
Period of Report
2024-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240405_8k.htm   iXBRL 8-K 28310
2 EXHIBIT 99.1 ex_650440.htm EX-99.1 25112
7 logo.jpg GRAPHIC 6166
  Complete submission text file 0001437749-24-011212.txt   202246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240401.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240401_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240401_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240401_pre.xml EX-101.PRE 11583
19 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240405_8k_htm.xml XML 2821
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24826517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)